SBI Life Insurance Company Limited SBILIFE NIFTY50NSEFINANCIAL
SBI Life Insurance Company Limited operates as a private life insurance company in India. The company's life insurance business comprises individual and group life insurance products, including participating, non-participating, pension, group gratuity, group leave encashment, group superannuation, group immediate annuity, unit-linked and variable insurance products, health, and micro insurance. It also provides accident and disability benefit, level term, and critical illness insurance products. In addition, the company offers online savings, protection, retirement, and child life insurance plans, as well as wealth creation with insurance products; and corporate solutions, group loan protection, and group micro insurance plans. It offers its products through a multi-channel distribution network comprising individual agents, brokers, corporate agents, bancassurance partners, and certified insurance facilitators, as well as through various partner branches. The company was incorporated in 2000 and is based in Mumbai, India. SBI Life Insurance Company Limited is a subsidiary of State Bank of India.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Compounding revenue at 11.7% over 5 years.
- Profit CAGR of 12.8% over 5 years.
- Generates positive free cash flow.
CONS
- Trading at a high P/E of 74.1.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SBILIFE SBI Life Insurance Company Limited NIFTY50NSEFINANCIAL | 1,830.10 | 74.06 | ₹1.84 L Cr | 0.15% | - | 13.70% | 11.67% | 12.81% |
| 2 | HDFCBANK HDFC Bank Limited NIFTY50NSEAIFINANCIAL | 744.55 | 16.61 | ₹11.46 L Cr | 1.75% | - | 13.82% | 32.50% | 20.39% |
| 3 | ICICIBANK ICICI Bank Limited NIFTY50NSEAIFINANCIAL | 1,256.40 | 16.81 | ₹9.01 L Cr | 0.88% | - | 16.36% | 19.65% | 16.78% |
| 4 | SBIN State Bank of India NIFTY50NSEAIFINANCIALPSU | 964.40 | 10.58 | ₹8.90 L Cr | 1.80% | - | 15.48% | 12.19% | 14.39% |
| 5 | KOTAKBANK Kotak Mahindra Bank Limited NIFTY50NSEAIFINANCIAL | 384.20 | 19.80 | ₹3.82 L Cr | 0.13% | - | 11.39% | 14.58% | 8.92% |
| 6 | LICI Life Insurance Corporation of India NIFTY_MIDNSEFINANCIALPSU | 411.35 | 9.06 | ₹2.60 L Cr | 2.43% | - | 42.36% | 7.61% | 16.86% |
| 7 | SHRIRAMFIN Shriram Finance Limited NIFTY50NSEFINANCIAL | 947.15 | 17.79 | ₹2.23 L Cr | 1.46% | - | 16.38% | 15.48% | 18.59% |
| 8 | ICICIAMC ICICI PRUDENTIAL AMC LTD NIFTY_MIDNSEFINANCIAL | 3,538.50 | 53.19 | ₹1.75 L Cr | 0.70% | 98.30% | 85.80% | 28.94% | 29.58% |
| 9 | JIOFIN Jio Financial Services Limited NIFTY50NSEAIFINANCIAL | 238.95 | 99.15 | ₹1.58 L Cr | 0.21% | 1.63% | 1.21% | 407.38% | 268.28% |
Quarterly Results
Figures in INR.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 18,860.39 Cr | 23,062.35 Cr | 39,012.94 Cr | 46,110.25 Cr | 4,094.92 Cr |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | - | - | - | - |
| Pretax Income | 571.61 Cr | 840.61 Cr | 610.95 Cr | 597.53 Cr | 815.78 Cr |
| Tax Provision | 20.79 Cr | 27.10 Cr | 16.58 Cr | 20.79 Cr | 11.14 Cr |
| Net Income | 550.82 Cr | 813.51 Cr | 594.37 Cr | 576.74 Cr | 804.64 Cr |
| Diluted EPS | 5.49 | 8.11 | 5.93 | 5.75 | 8.02 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 80,639.04 Cr | 1.31 L Cr | 1.17 L Cr | 1.12 L Cr |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - |
| Operating Income | 1,582.75 Cr | 1,783.28 Cr | 1,951.24 Cr | 2,506.11 Cr | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | 21.99 Cr | 24.84 Cr | 9.13 Cr | 11.44 Cr | - |
| Pretax Income | - | 1,758.45 Cr | 1,942.11 Cr | 2,494.67 Cr | 2,537.40 Cr |
| Tax Provision | - | 37.87 Cr | 48.33 Cr | 81.37 Cr | 67.10 Cr |
| Net Income | - | 1,720.57 Cr | 1,893.78 Cr | 2,413.30 Cr | 2,470.30 Cr |
| Diluted EPS | - | 17.18 | 18.90 | 24.07 | 24.62 |
Compounded Sales Growth
| 5 Years: | 11.67% |
| 1 Year: | -82.20% |
Compounded Profit Growth
| 5 Years: | 12.81% |
| 1 Year: | -1.10% |
Stock Price Performance
| 1 Year: | +0.42% |
| 6 Months: | -9.04% |
| 3 Months: | -13.13% |
| 1 Month: | +0.77% |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 3.15 L Cr | 3.98 L Cr | 4.57 L Cr | 5.00 L Cr |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | - | 1,591.22 Cr | 4,740.63 Cr | 1,783.58 Cr | 3,207.94 Cr |
| Inventory | - | - | - | - | - |
| Receivables | 447.26 Cr | 382.15 Cr | 778.63 Cr | 788.02 Cr | - |
| Total Liabilities | - | 3.02 L Cr | 3.83 L Cr | 4.40 L Cr | 4.81 L Cr |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
| Total Equity | - | 13,017.48 Cr | 14,908.56 Cr | 16,985.35 Cr | 19,086.00 Cr |
| Shares Outstanding | - | 100.09 Cr | 100.15 Cr | 100.21 Cr | 100.31 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - |
| Investing Cash Flow | - | -30,203.00 Cr | -31,221.33 Cr | -21,788.85 Cr | -35,317.99 Cr |
| Financing Cash Flow | - | -415.10 Cr | -227.32 Cr | -214.81 Cr | -178.80 Cr |
| Capital Expenditure | - | -63.20 Cr | -114.39 Cr | -106.19 Cr | -185.00 Cr |
| Free Cash Flow | - | 28,592.84 Cr | 29,007.47 Cr | 25,440.46 Cr | 34,337.67 Cr |
| Net Change in Cash | - | -1,962.05 Cr | -2,326.79 Cr | 3,542.99 Cr | -974.12 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | 2.2% | 1.5% | 2.1% | - |
| Net Margin % | - | 2.1% | 1.4% | 2.1% | 2.2% |
| ROE % | - | 13.2% | 12.7% | 14.2% | 12.9% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SBILIFE